Financial Calendar

POXEL (Euronext - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and NASH, announces its schedule for the publication of financial information for 2019.

Event Date*
2018 Fourth Quarter Financial Update February 12, 2019
2018 Full Year Statement March 21, 2019
2019 First Quarter Financial Update April 8, 2019
2019 Second Quarter Financial Update July 15, 2019
2019 First Half Statement August 26, 2019
2019 Third Quarter Financial Update October 7, 2019
2019 Fourth Quarter Financial Update February 12, 2020

*Subject to modification.